Vol 12, No 5 (October 31, 2023): Chinese Clinical Oncology

Editorial Commentary

Effective adjuvant therapy following curative hepatectomy for hepatocellular carcinoma: a myth or reality

Kelvin K. C. Ng

PDF Pages: 46 Full Text (616) Peer Review File COI Form Open Access

Pembrolizumab: a potential game-changer in the treatment of advanced hepatocellular carcinoma

Dmitrii Shek, Golo Ahlenstiel

PDF Pages: 47 Full Text (1016) Peer Review File COI Form Open Access

Could a novel category of molecular testing be emerging?

Carolina Ferraz, Laura Sterian Ward

PDF Pages: 48 Full Text (713) Peer Review File COI Form Open Access

Revolutionizing hepatocellular carcinoma treatment: the advent of a new era of adjuvant therapy

Joshua Sheng Hao Lim, Vishal G. Shelat

PDF Pages: 49 Full Text (763) Peer Review File COI Form Open Access

Original Article

Tislelizumab plus chemotherapy vs. pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer: systematic review and indirect comparison of randomized trials

Andrea Messori, Melania Rivano, Marco Chiumente, Daniele Mengato

PDF Pages: 50 Full Text (1700) Reporting Checklist Peer Review File COI Form Open Access

Associations between marital quality and the prognosis of breast cancer in young Chinese women: 10.3-year median follow-up

Lili Yuan, Huilong Cai, Weiwei An, Weiguang Yuan, Eric M. Toloza, Ying Song, Jing An

PDF Pages: 51 Full Text (1047) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Expression of YAP suppresses cell proliferation and elevates the sensitivity of chemotherapy in retinoblastoma cells through lipid-peroxidation induced ferroptosis

Liting Zhong, Xuejiao Meng, Jingjing Huang, Wenwen Hao, Yajing Zuo

PDF Pages: 52 Full Text (1704) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Review Article

Assessing surrogacy using restricted mean survival time ratio for overall survival in liver cancer: a narrative review

Tiffany H. Leung, James C. Ho, Xiaofei Wang, Herbert Pang

PDF Pages: 53 Full Text (1120) Reporting Checklist Peer Review File COI Form Open Access

Brave new world—new and emerging treatments for gastric cancer

Emer Lynch, Austin G. Duffy, Ronan J. Kelly

PDF Pages: 54 Full Text (1767) Peer Review File COI Form Open Access

Targeting ERBB2/HER2 genetic alterations: an expanding therapeutic opportunity in gastrointestinal cancers

Binbin Zheng-Lin, Rondell P. Graham, Tanios S. Bekaii-Saab

PDF Pages: 55 Full Text (2203) Peer Review File COI Form Open Access

Hippocampal sparing radiation therapy for brain metastases: treatment techniques and clinical implementation

Kaley Woods, Zhilei Liu Shen, Zhengzheng Xu, Hualin Zhang, Yutaka Natsuaki, Karen Cheng, Vivian Li, Nathan Kim, Lijun Ma, Eric Chang

PDF Pages: 56 Full Text (3037) Peer Review File COI Form Open Access

Case Report

Boosted abscopal effect from radiotherapy and pembrolizumab in anaplastic thyroid cancer: a mini-review and case report

Doreen Goh, Kok Hing Lim, Siti Radhziah Binte Sudirman, Mei-Kim Ang, Melvin Lee Kiang Chua, Chwee Ming Lim

PDF Pages: 57 Full Text (1835) Reporting Checklist Peer Review File COI Form Open Access